tirzepatide for diabetes wichita approved obesity Cipla launches Yurpeak® (tirzepatide), a one-weekly injectable therapy managing and FDA Approves Tirzepatide, A Potential

No doubt, by the time you read this, these numbers will have increased exponentially

In the latest, researchers from the Cleveland Clinic compared patients who were prescribed a GLP-1 drug for obesity or type 2 diabetes to those on non-GLP-1 meds

Interestingly, these benefits were observed even in some patients who didnt experience dramatic weight loss, suggesting that semaglutide has a direct impact on metabolic health

If your urine is consistently dark, you are not drinking enough, regardless of what the volume targets say

6.1 Liver diseases Chronic liver disease (CLD) is a significant source of death and disability globally, with 2 million people dying from it every year (Younossi et al., 2023)